US Stocks New Stock Analysis | Profitability challenge awaits solution, what does Bedford Medical (BDMD.US) rely on to impress investors?

From the market trends perspective, Baideli Medical has been falling steadily since its listing, with the stock price plummeting by 62% since October, clearly not favored by market investors.

Zhitong FinanceNov 7, 2024 09:55

Nine companies, including SF Express, Aggregate Data, Jinyuan Hydrogen Energy, Weisheng Pharmaceutical, Shenghe Biotech, Egg, and Baide Medical, are planning to be listed in Hong Kong/US to file supplementary material requirements (feedback)

Requirements for supplementary materials for overseas issuance and listing registration (September 15, 2023 to September 21, 2023)

瑞恩資本RyanbenCapitalSep 23, 2023 13:17

Baide Healthcare's plan to go public with ExcelFin (XFIN.US) in the US was previously suspended on the eve of its listing in Hong Kong

The Zhitong Finance App learned that on June 26, the Chinese medical technology company Baide Medical announced that it plans to merge with ExcelFin Acquisition Corp. (XFIN.US), a special purpose acquisition company (SPAC). After the merger is completed, the company will operate as Baird Medical Investment Holdings Limited and be listed on the NASDAQ under the stock code “BDMD.” According to the merger agreement, the equity value before the merger was 300 million US dollars, and the company's implied estimated corporate price after the merger

Zhitong FinanceJun 28, 2023 16:18

What does it mean for Baide Healthcare (06678) to be suspended from listing and undercover scrapping?

The Zhitong Finance App learned that Baide Healthcare (06678), which had already announced that it would be listed on the Hong Kong Stock Exchange on October 5, issued another notice on the evening of October 3 stating that the sale would be delayed, while the dark market transaction on October 3 was deemed null and void. On October 3, Baide Medical first announced the placement results, stating that the company sold 248 million shares globally, of which Hong Kong sold about 18.18% and international placements accounted for 81.82%. The final sale price has been determined at HK$1.40 per share, or 2,000 shares per lot. It is expected that the shares will be sold at 9:00 a.m. on October 5 (Wednesday) (Hong Kong time)

Zhitong FinanceOct 4, 2022 11:04

Dark Market Intelligence | Baide Healthcare closed down 37.14%, with each hand eroded HK$1,040

According to previously disclosed information, the number of subscribers to Baide Medical's public placement was 3,350, and the first-hand winning rate was 100%.

Futu NewsOct 3, 2022 19:24

Bank of China-Backed Betters Medical Raises $33 Million in Hong Kong IPO

MT NewswiresOct 3, 2022 15:55